Patents by Inventor Szymon Kosinski

Szymon Kosinski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11905228
    Abstract: This application relates, in part, to novel salts represented by the following structure of Formula (1): wherein R1a is selected from the group consisting of hydrogen and optionally substituted alkyl (e.g., unsubstituted C1-6 alkyl, e.g., —CH3); R1b is optionally substituted alkyl (e.g., unsubstituted C1-6 alkyl, e.g., —CH3); each occurrence of R2 and R3 is independently selected from the group consisting of hydrogen, optionally substituted alkyl, optionally substituted cycloalkyl, and optionally substituted aryl; R2 and R3 can combine with each other to form optionally substituted cycloalkyl; each m and n is independently an integer ranging from 1 to 20 (e.g., m and n is independently an integer ranging from 1 to 5); and each of Q1? and Q2? is independently a counterion (e.g., each of Q1? and Q2? is independently a counterion selected from the group consisting of chloride, bromide, fluoride, iodide, acetate, carboxylate, hydrogen sulfate, nitrate, and phenolate, and sulfonate, e.g.
    Type: Grant
    Filed: August 5, 2021
    Date of Patent: February 20, 2024
    Assignee: Aditya Birla Chemicals (USA), Inc.
    Inventors: Szymon Kosinski, Stefan J. Pastine, Ulhas Bhatt
  • Patent number: 11731932
    Abstract: Provided herein are silicon-containing recyclable polyamino compounds; epoxy resin compositions containing these silicon-containing reworkable or recyclable polyamino compounds; and methods of their use.
    Type: Grant
    Filed: November 2, 2020
    Date of Patent: August 22, 2023
    Assignee: Aditya Birla Chemicals (USA), Inc.
    Inventors: Szymon Kosinski, Stefan J. Pastine
  • Publication number: 20230192637
    Abstract: A process for the production of dihydronepetalactone including hydrogenating nepetalactone in the presence of a catalytic metal is provided. The catalytic metal may include nickel. The process may be performed in an aqueous medium.
    Type: Application
    Filed: April 14, 2021
    Publication date: June 22, 2023
    Applicant: Zymergen Inc.
    Inventors: Szymon Kosinski, Liza Lopez, Wilson Chau, Anil Guram, Ying Lin Louie
  • Patent number: 11542224
    Abstract: The present invention relates to the reduction of polycyano compounds to produce polyamines, in particular diaminoacetal and diaminoketal compounds, and their use as curing agents in epoxy resin compositions. The reduction with molecular hydrogen can be carried out using a metal catalyst selected from GROUP VIII and a catalytic promoter. The reduction can include anhydrous or aqueous ammonia. The reaction can be carried out in continuous and batch modes with catalyst and solvent recycling. The epoxy resin composition consisting of an epoxy resin and a polyamine curing agent that can be used in fiber-reinforced composite materials, coating materials, and the like.
    Type: Grant
    Filed: April 17, 2020
    Date of Patent: January 3, 2023
    Assignee: Aditya Birla Chemicals (USA), Inc.
    Inventors: Szymon Kosinski, Stefan J. Pastine
  • Publication number: 20220356145
    Abstract: Provided herein are silicon-containing recyclable polyamino compounds; epoxy resin compositions containing these silicon-containing reworkable or recyclable polyamino compounds; and methods of their use.
    Type: Application
    Filed: November 2, 2020
    Publication date: November 10, 2022
    Inventors: Szymon Kosinski, Stefan J. Pastine
  • Publication number: 20220024854
    Abstract: This application relates, in part, to novel salts represented by the following structure of Formula (1): wherein R1a is selected from the group consisting of hydrogen and optionally substituted alkyl (e.g., unsubstituted C1-6 alkyl, e.g., —CH3); R1b is optionally substituted alkyl (e.g., unsubstituted C1-6 alkyl, e.g., —CH3); each occurrence of R2 and R3 is independently selected from the group consisting of hydrogen, optionally substituted alkyl, optionally substituted cycloalkyl, and optionally substituted aryl; R2 and R3 can combine with each other to form optionally substituted cycloalkyl; each m and n is independently an integer ranging from 1 to 20 (e.g., m and n is independently an integer ranging from 1 to 5); and each of Q1? and Q2? is independently a counterion (e.g., each of Q1? and Q2? is independently a counterion selected from the group consisting of chloride, bromide, fluoride, iodide, acetate, carboxylate, hydrogen sulfate, nitrate, and phenolate, and sulfonate, e.g.
    Type: Application
    Filed: August 5, 2021
    Publication date: January 27, 2022
    Inventors: Szymon Kosinski, Stefan J. Pastine, Ulhas Bhatt
  • Patent number: 11124473
    Abstract: This application relates, in part, to novel salts represented by the following structure of Formula (1): wherein R1a is selected from the group consisting of hydrogen and optionally substituted alkyl (e.g., unsubstituted C1-6 alkyl, e.g., —CH3); R1b is optionally substituted alkyl (e.g., unsubstituted C1-6 alkyl, e.g., —CH3); each occurrence of R2 and R3 is independently selected from the group consisting of hydrogen, optionally substituted alkyl, optionally substituted cycloalkyl, and optionally substituted aryl; R2 and R3 can combine with each other to form optionally substituted cycloalkyl; each m and n is independently an integer ranging from 1 to 20 (e.g., m and n is independently an integer ranging from 1 to 5); and each of Q1? and Q2? is independently a counterion (e.g., each of Q1? and Q2? is independently a counterion selected from the group consisting of chloride, bromide, fluoride, iodide, acetate, carboxylate, hydrogen sulfate, nitrate, and phenolate, and sulfonate, e.g.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: September 21, 2021
    Assignee: Aditya Birla Chemicals (USA) LLC
    Inventors: Szymon Kosinski, Stefan J. Pastine, Ulhas Bhatt
  • Publication number: 20210261721
    Abstract: An epoxy resin composition comprises about 70 wt % to about 95 wt % by weight of the composition of an epoxy component; and a curing component comprising about 5 wt % to about 30 wt % by weight of the composition, wherein the curing component is includes an imidazole; wherein the epoxy component and the curing component react together at a temperature of about 100 C to about 130 C to form a substantially cured reaction product in about 10 minutes or less and the cured product shows high tensile and flexural strength.
    Type: Application
    Filed: June 14, 2019
    Publication date: August 26, 2021
    Applicant: Zymergen Inc.
    Inventors: Szymon Kosinski, Stephen Lo, Timothy Mauldin, Shilpa Naresh Raja, Nicole G. Ricapito, Adam Safir
  • Patent number: 10919839
    Abstract: Provided herein are silicon-containing recyclable polyamino compounds; epoxy resin compositions containing these silicon-containing reworkable or recyclable polyamino compounds; and methods of their use.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: February 16, 2021
    Assignee: Aditya Birla Chemicals (USA) LLC
    Inventors: Szymon Kosinski, Stefan J. Pastine
  • Publication number: 20200317604
    Abstract: The present invention relates to the reduction of polycyano compounds to produce polyamines, in particular diaminoacetal and diaminoketal compounds, and their use as curing agents in epoxy resin compositions. The reduction with molecular hydrogen can be carried out using a metal catalyst selected from GROUP VIII and a catalytic promoter. The reduction can include anhydrous or aqueous ammonia. The reaction can be carried out in continuous and batch modes with catalyst and solvent recycling. The epoxy resin composition consisting of an epoxy resin and a polyamine curing agent that can be used in fiber-reinforced composite materials, coating materials, and the like.
    Type: Application
    Filed: April 17, 2020
    Publication date: October 8, 2020
    Inventors: Szymon Kosinski, Stefan J. Pastine
  • Publication number: 20190284128
    Abstract: The present invention relates to the reduction of polycyano compounds to produce polyamines, in particular diaminoacetal and diaminoketal compounds, and their use as curing agents in epoxy resin compositions. The reduction with molecular hydrogen can be carried out using a metal catalyst selected from GROUP VIII and a catalytic promoter. The reduction can include anhydrous or aqueous ammonia. The reaction can be carried out in continuous and batch modes with catalyst and solvent recycling. The epoxy resin composition consisting of an epoxy resin and a polyamine curing agent that can be used in fiber-reinforced composite materials, coating materials, and the like.
    Type: Application
    Filed: January 3, 2019
    Publication date: September 19, 2019
    Inventors: Szymon Kosinski, Stefan J. Pastine
  • Patent number: 10214479
    Abstract: The present invention relates to the reduction of polycyano compounds to produce polyamines, in particular diaminoacetal and diaminoketal compounds, and their use as curing agents in epoxy resin compositions. The reduction with molecular hydrogen can be carried out using a metal catalyst selected from GROUP VIII and a catalytic promoter. The reduction can include anhydrous or aqueous ammonia. The reaction can be carried out in continuous and batch modes with catalyst and solvent recycling. The epoxy resin composition consisting of an epoxy resin and a polyamine curing agent that can be used in fiber-reinforced composite materials, coating materials, and the like.
    Type: Grant
    Filed: January 3, 2017
    Date of Patent: February 26, 2019
    Assignee: Connora Technologies, Inc.
    Inventors: Szymon Kosinski, Stefan J. Pastine
  • Publication number: 20190016667
    Abstract: This application relates, in part, to novel salts represented by the following structure of Formula (1): wherein R1a is selected from the group consisting of hydrogen and optionally substituted alkyl (e.g., unsubstituted C1-6 alkyl, e.g., —CH3); R1b is optionally substituted alkyl (e.g., unsubstituted C1-6 alkyl, e.g., —CH3); each occurrence of R2 and R3 is independently selected from the group consisting of hydrogen, optionally substituted alkyl, optionally substituted cycloalkyl, and optionally substituted aryl; R2 and R3 can combine with each other to form optionally substituted cycloalkyl; each m and n is independently an integer ranging from 1 to 20 (e.g., m and n is independently an integer ranging from 1 to 5); and each of Q1? and Q2? is independently a counterion (e.g., each of Q1? and Q2? is independently a counterion selected from the group consisting of chloride, bromide, fluoride, iodide, acetate, carboxylate, hydrogen sulfate, nitrate, and phenolate, and sulfonate, e.g.
    Type: Application
    Filed: June 11, 2018
    Publication date: January 17, 2019
    Inventors: Szymon Kosinski, Stefan J. Pastine, Ulhas Bhatt
  • Publication number: 20190016870
    Abstract: Provided herein are silicon-containing recyclable polyamino compounds; epoxy resin compositions containing these silicon-containing reworkable or recyclable polyamino compounds; and methods of their use.
    Type: Application
    Filed: June 11, 2018
    Publication date: January 17, 2019
    Inventors: Szymon Kosinski, Stefan J. Pastine
  • Patent number: 7973157
    Abstract: Novel processes for the purification of an imino or amino sugar, such as D-1-deoxygalactonojirimycin (DGJ). Particularly, there are described processes for the purification of multi-kilogram scale sugars using hydrochloric acid.
    Type: Grant
    Filed: June 8, 2006
    Date of Patent: July 5, 2011
    Assignee: Amicus Therapeutics, Inc.
    Inventors: Michael Major, Robert Peterson, Szymon Kosinski
  • Patent number: 7928062
    Abstract: Methods are disclosed for inhibiting or disrupting Janus tyrosine kinase 3 (Jak3) dependent function in cells of lymphoid or myeloid origin, especially for blocking proliferation and function of lymphocytes (e.g., T-cells, B-cells). A Mannich base compound, or a derivative or modified compound, is employed which is capable of selectively inhibiting Jak3 while affecting other protein tyrosine kinase activities to a lesser extent or not at all, to provide beneficial effects such as mitigation of transplant rejection and alleviation of allergic responses with fewer side effects than with conventional immunosuppressive agents.
    Type: Grant
    Filed: November 5, 2007
    Date of Patent: April 19, 2011
    Assignee: Board of Regents of the University of Texas System
    Inventors: Robert A. Kirken, Barry D. Kahan, Stanislaw M. Stepkowski, Waldemar Priebe, Izabela Fokt, Szymon Kosinski
  • Publication number: 20080167220
    Abstract: Methods are disclosed for inhibiting or disrupting Janus tyrosine kinase 3 (Jak3) dependent function in cells of lymphoid or myeloid origin, especially for blocking proliferation and function of lymphocytes (e.g., T-cells, B-cells). A Mannich base compound, or a derivative or modified compound, is employed which is capable of selectively inhibiting Jak3 while affecting other protein tyrosine kinase activities to a lesser extent or not at all, to provide beneficial effects such as mitigation of transplant rejection and alleviation of allergic responses with fewer side effects than with conventional immunosuppressive agents.
    Type: Application
    Filed: November 5, 2007
    Publication date: July 10, 2008
    Applicant: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Robert A. KIRKEN, Barry D. KAHAN, Stanislaw M. STEPKOWSKI, Waldemar PRIEBE, Izabela FOKT, Szymon KOSINSKI
  • Patent number: 7365096
    Abstract: Methods are disclosed for inhibiting or disrupting Janus tyrosine kinase 3 (Jak3) dependent function in cells of lymphoid or myeloid origin, especially for blocking proliferation and function of lymphocytes (e.g., T-cells, B-cells). A Mannich base compound, or a derivative or modified compound, is employed which is capable of selectively inhibiting Jak3 while affecting other protein tyrosine kinase activities to a lesser extent or not at all, to provide beneficial effects such as mitigation of transplant rejection and alleviation of allergic responses with fewer side effects than with conventional immunosuppressive agents.
    Type: Grant
    Filed: December 9, 2003
    Date of Patent: April 29, 2008
    Assignee: Board of Regents, The University of Texas System
    Inventors: Robert A. Kirken, Barry D. Kahan, Stanislaw M. Stepkowski, Waldemar Priebe, Izabela Fokt, Szymon Kosinski
  • Publication number: 20060293508
    Abstract: Described are novel processes for the synthesis triflated sugars. These sugars are useful for the production of compounds, such as D-1-deoxynojirimycin (DNJ) and D-1-deoxygalactonojirimycin (DGJ). In particular, described is a multi-kilogram scale stabilization method for the synthesis of imino sugars.
    Type: Application
    Filed: June 8, 2006
    Publication date: December 28, 2006
    Inventors: Michael Major, Robert Peterson, Szymon Kosinski
  • Publication number: 20060293515
    Abstract: Novel processes for the purification of an imino or amino sugar, such as D-1-deoxygalactonojirimycin (DGJ). Particularly, there are described processes for the purification of multi-kilogram scale sugars using hydrochloric acid.
    Type: Application
    Filed: June 8, 2006
    Publication date: December 28, 2006
    Inventors: Michael Major, Robert Peterson, Szymon Kosinski